John F. Paolini
Executive VP & Chief Medical OfficerDr. John F. Paolini, MD, Ph.D, FACC, serves as Chief Medical Officer at Kiniksa Pharmaceuticals International, plc (formerly known as Kiniksa Pharmaceuticals, Ltd.) since August 2016 and serves as its Executive Vice President from January 2025 and was its Senior Vice President until December 2024. He served as Chief Medical Officer of Cerenis Therapeutics SA since August 2011 until July 2015. From August 2015 to August 2016, Dr. Paolini served as Clinical Research Head of the Cardiovascular and Metabolic Diseases Research Unit at Pfizer Inc. Dr. Paolini is responsible for the strategic planning and execution of the clinical trials for Cerenis' portfolio of novel cardiovascular therapies and importantly. Dr. Paolini has many years of clinical and research experience in cardiovascular disease. He focused on clinical development in the pharmaceutical industry: notably, at Merck & Co., Inc., he led development programs of novel therapies for dislipidemic patients (Tredaptive(R) the Nicotinic acid/laropripant combination and Vytorin(R)/Inegy(R) the Ezetimibe/Simvastatin combination tablet) and at Bayer Healthcare Pharmaceuticals, he led the clinical development program for a novel anticoagulant agent for patients with atrial fibrillation (Xarelto,(R) the direct factor Xa inhibitor, rivaroxaban). He is board certified in Cardiovascular Disease, a Fellow of the American College of Cardiology and has served as a Clinical Associate in Cardiovascular Medicine at the Hospital of the University of Pennsylvania. Dr. Paolini has been involved in the publication of over fifty abstracts and scientific papers. Dr. Paolini holds an M.D., Ph.D. from Duke University School of Medicine and a B.A. and a Bachelor of Science, or B.S., from Tulane University and completed his internship, residency and fellowship in Internal Medicine and Cardiology from Brigham and Women's Hospital, Boston.
Positions
- Company NameKiniksa Pharmaceuticals International, plcStock CodeKNSAPositionExecutive VP & Chief Medical OfficerColleagues
- SKSanjiv K. PatelCEO & Chairman of the Board
- RMRoss Michael MoatPresident, Executive VP, COO & Principal Operating Officer
- MAMark A. RagosaExecutive VP & CFO
- ETEben TessariConsultant
- KJKimberly Johnston PopovitsIndependent Director
- TRThomas Robert MalleyIndependent Director
- SRStephen Richard BiggarIndependent Director
- RJRobert J. DesnickChairman of Scientific Advisory Board
